Chemical Structure : CTCE-9908
CAS No.: 1030384-98-5
Catalog No.: PC-23668Not For Human Use, Lab Use Only.
CTCE-9908 is a potent and selective CXCR4 antagonist, induces mitotic catastrophe in ovarian cancer cells.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 2 mg | $238 | In stock | |
| 5 mg | $398 | In stock | |
| 10 mg | $598 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CTCE-9908 is a potent and selective CXCR4 antagonist, induces mitotic catastrophe in ovarian cancer cells.
CTCE-9908 inhibits migration and growth in CXCR4-expressing ovarian cancer cells.
CTCE-9908 induces multinucleation and G2-M arrest in ovarian cancer cells.
CTCE-9908 induces DNA re-replication and abnormal mitoses in ovarian cancer cells.
CTCE-9908 significantly reduced lung metastasis of osteosarcoma and melanoma cells in animal models.
| M.Wt | 1927.29 | |
| Formula | C86H147N27O23 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
L-Lysinamide, N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)- |
|
1. Kim SY, et al. Clin Exp Metastasis. 2008;25(3):201-11.
2. Porvasnik S, et al. Prostate. 2009 Sep 15;69(13):1460-9.
3. Kwong J, et al. Mol Cancer Ther. 2009 Jul;8(7):1893-905.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright